Curcumin compound improves effectiveness of head and neck cancer treatment

May 19, 2011 in Cancer

A primary reason that head and neck cancer treatments fail is the tumor cells become resistant to chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive Cancer Center have found that a compound derived from the Indian spice curcumin can help cells overcome that resistance.

When researchers added a curcumin-based compound, called FLLL32, to head and neck cancer cell lines, they were able to cut the dose of the chemotherapy by four while still killing equally as well as the higher dose of cisplatin without FLLL32.

The study appears this week in the Archives of Otolaryngology – Head and Neck Surgery.

"This work opens the possibility of using lower, less toxic doses of cisplatin to achieve an equivalent or enhanced tumor kill. Typically, when cells become resistant to cisplatin, we have to give increasingly higher doses. But this drug is so toxic that patients who survive treatment often experience long-term side effects from the treatment," says senior study author Thomas Carey, Ph.D., professor of otolaryngology and pharmacology at the U-M Medical School and co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center.

That tumors become resistant to cisplatin is a major reason why head and neck cancer patients frequently see their cancer return or spread. It also plays a big role in why five-year survival for head and neck cancer has not improved in the past three decades.

FLLL32 is designed to sensitize at a molecular level to the antitumor effects of cisplatin. It targets a key type of protein called STAT3 that is seen at high levels in about 82 percent of head and neck cancers. High levels of STAT3 are linked to problems with normal cell death processes, which allow cancer cells to survive treatment. STAT3 activation has been associated with cisplatin resistance in head and neck cancer.

is known to inhibit STAT3 function, but it is not well-absorbed by the body. FLLL32 was developed by researchers at Ohio State University to be more amenable to use in people. The current study used the compound only in cell lines in the laboratory.

In the current study, researchers compared varying doses of cisplatin alone with varying doses of cisplatin plus FLLL32 against two sets of head and cells: one line that was sensitive to cisplatin and one line that was resistant.

They found that FLLL32 decreased the activation levels of STAT3, sensitizing both resistant and sensitive tumor cells to cisplatin. Further, lower doses of cisplatin with FLLL32 were equally effective at killing cancer cells as the higher doses of cisplatin alone.

Separate studies suggest FLLL32 may not be well-absorbed by the body and researchers are developing a next generation compound that they hope improves on that. The U-M team plans to further study this newer compound for its potential as part of treatment. Clinical trials using this compound are not currently available.

More information: Reference: Archives of Otolaryngology – Head and Neck Surgery, Vol. 137, No. 5, pp. 499-507

Provided by University of Michigan search and more info website

4.7 /5 (3 votes)  

Rank 4.7 /5 (3 votes)
Relevant PhysicsForums posts
  • Poor nutrition leading to overeating?
    created5 hours ago
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Breast MRI helps predict chemotherapy's effectiveness

Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

Colonoscopy may detect curable cancer in elderly: study

(HealthDay) -- Colonoscopies helped doctors detect a high rate of curable cancer in elderly people who had the screening for the first time, a new study indicates.

Cancer created 11 hours ago | popularity 5 / 5 (2) | comments 0

Scientists see potential in novel leukemia treatment

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill ...

Cancer created 12 hours ago | popularity 5 / 5 (1) | comments 0

Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part ...

Cancer created 12 hours ago | popularity not rated yet | comments 0

Scientists unravel role of fusion gene in prostate cancer

Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...

Cancer created 14 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast


Scientists turn patients' skin cells into heart muscle cells to repair their damaged hearts

For the first time scientists have succeeded in taking skin cells from heart failure patients and reprogramming them to transform into healthy, new heart muscle cells that are capable of integrating with existing heart tissue.

Scientists start explaining Fat Bastard's vicious cycle

Fat Bastard's revelation "I eat because I'm depressed and I'm depressed because I eat" in the Austin Powers film series may be explained by sophisticated neuroscience research being undertaken by scientists affiliated with ...

Socioeconomics may affect toddlers' exposure to flame retardants

A Duke University-led study of North Carolina toddlers suggests that exposure to potentially toxic flame-retardant chemicals may be higher in nonwhite toddlers than in white toddlers.

Kids suffer long-term from parents' smoking: study

Children exposed to their parents' cigarette smoke are at greater risk of suffering serious cardiovascular health problems later in life, a study showed Wednesday.

New study confirms value of cardiac output monitor

(Medical Xpress) -- A new Australian study has confirmed the accuracy of a modern non-invasive cardiac output monitor that can replace a 40-year-old standard in this field.

South Korean smokers finally start to feel the heat

After decades of indifference, big businesses and the government are turning up the heat on smokers in South Korea, a nation with one of the developed world's highest male smoking rates.